Lv6
3160 积分 2022-11-17 加入
Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravis
3个月前
已完结
Effective use of BCMA-targeting bispecific T cell-engaging antibody in treatment-refractory LRP4+ myasthenia gravis
3个月前
已完结
New therapies for autoimmune myasthenia gravis
3个月前
已完结
Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders
3个月前
已完结
What Is Myasthenia Gravis?
3个月前
已完结
Memory B cells
4个月前
已完结
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
4个月前
已完结
A small, but vocal, brain
4个月前
已关闭
Therapeutic approaches in adults with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A review of current evidence
4个月前
已完结
Migraine: epidemiology and systems of care
4个月前
已完结
皖公网安备34019202002308
